Ultralife (ULBI) Net Income towards Common Stockholders (2010 - 2026)

Ultralife's Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at -$471000.0 for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 125.07% year-over-year to -$471000.0 in Q1 2026; TTM through Mar 2026 was -$8.3 million, a 254.9% decrease from a year earlier, with the FY2025 full-year figure at -$6.0 million, down 193.22% from the prior year.
• Net Income towards Common Stockholders climbed to -$471000.0 in Q1 2026 per ULBI's latest filing, from -$7.5 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $3.3 million in Q2 2023 and bottomed at -$7.5 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is $279000.0 (2024), against an average of $355647.1.
• Across the five-year window, Net Income towards Common Stockholders jumped 966.87% in 2024 and sank 3683.17% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$1.2 million in 2022, then jumped by 340.1% to $2.8 million in 2023, then tumbled by 92.7% to $208000.0 in 2024, then sank by 3683.17% to -$7.5 million in 2025, then surged by 93.68% to -$471000.0 in 2026.
• Per Business Quant, the three latest ULBI Net Income towards Common Stockholders figures stand at -$471000.0 (Q1 2026), -$7.5 million (Q4 2025), and -$1.2 million (Q3 2025).